3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Sequus Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. Doxorubicin hydrochloride (liposomal) - Sarcoma, Kaposi, HIV Infections | Phase 3 | Completed | Sequus Pharmaceuticals | 2005-06-24 | ||
| Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma Doxorubicin hydrochloride (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections | Phase 3 | Completed | Sequus Pharmaceuticals | 220 | 2005-06-24 | |
| A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma Doxorubicin hydrochloride (liposomal) - Sarcoma, Kaposi, HIV Infections | Phase 3 | Completed | Sequus Pharmaceuticals | 2005-06-24 |
Acquired Immunodeficiency Syndrome (3) · HIV Infections (3) · Sarcoma, Kaposi (3)
Doxorubicin (3) · Liposomes (3) · Bleomycin (1) · Vincristine (1)
United States (3)